Quarterly ResultAug 10, 2026, 05:03 PM
BioForce Nanosciences Pivots to Oil & Gas, Reports Q2 Net Income $238K
AI Summary
BioForce Nanosciences Holdings, Inc. announced a significant strategic pivot, changing its business operations from vitamin supplements to the oil and gas industry in June 2026. This change followed Nexus Capital Investments, Inc. becoming the majority shareholder in April 2026. For the second quarter ended June 30, 2026, the company reported a net income of $238,682, a substantial improvement from a net loss of $122,781 in the prior year, largely due to debt forgiveness and a legal settlement. The company also appointed new management and established an advisory board.
Key Highlights
- Changed business operations from vitamin supplements to the oil and gas industry in June 2026.
- Reported Q2 2026 net income of $238,682, a significant improvement from a $122,781 net loss in Q2 2025.
- Six-month net income was $136,271, compared to a $1,058,238 net loss in the prior year period.
- Total assets increased to $2,388,075 at June 30, 2026, from $786 at December 31, 2025.
- Stockholders' equity shifted to $2,303,308 at June 30, 2026, from a $618,543 deficit at December 31, 2025.
- Received assignment of 11 federal oil and gas leases covering approximately 19,957 acres in Nevada.
- Merle Ferguson, a director, forgave $502,373 in accrued compensation and other amounts due.
- Richard Kaiser appointed interim CEO; Scott Mager appointed General Counsel and Director.
Price Impact
More from BFNH